SCHEMBL12829995

SCHEMBL12829995

Cc1oc(-c2ccccc2)cc1C(=O)Nc1csc(-c2ccc(Cl)cc2)c1C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.54
▸ RAB9A P51151 1/20 0.54
▸ ALDH1A1 P00352 9/20 0.53
▸ HPGD P15428 4/20 0.53
▸ LMNA P02545 3/20 0.53
▸ MEN1 O00255 6/20 0.50
▸ KMT2A Q03164 6/20 0.50
▸ CYP1A2 P05177 3/20 0.48
▸ MAPT P10636 3/20 0.48
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ CYP2C19 P33261 2/20 0.48
▸ ALOX12 P18054 2/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ PKM P14618 2/20 0.45
▸ S100A4 P26447 1/20 0.44
▸ KDM4E B2RXH2 3/20 0.43
▸ KDM1A O60341 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12756508 0.92 ALDH1A1 (0.54) NPC1RAB9AALDH1A1HPGDLMNA
SCHEMBL12756509 0.88 HPGD (0.46) NPC1RAB9AHPGDMEN1KMT2A
SCHEMBL1954313 0.82 ANO1 (0.64) MEN1KMT2AANO1
SCHEMBL12756516 0.81 TP53 (0.57) NPC1ALDH1A1MEN1KMT2AMAPT
SCHEMBL12831005 0.80 MEN1 (0.55) ALDH1A1HPGDLMNAMEN1KMT2A
SCHEMBL12756498 0.79 ANO1 (0.46) KDM4EANO1NPSR1
SCHEMBL12756507 0.79 HPGD (0.48) NPC1RAB9AALDH1A1HPGDLMNA
SCHEMBL12756890 0.78 PPARG (0.56) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL12756545 0.78 ANO1 (0.49) NPC1RAB9AALDH1A1HPGDLMNA
SCHEMBL1490373 0.78 KMT2A (0.52) NPC1RAB9AALDH1A1HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 — — US disclosed
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 — — US disclosed
WO-2011034962-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2011-03-24 — — WO disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 NPC1 262/4885RAB9A 1174/4885ALDH1A1 4409/4885
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 NPC1 262/4885RAB9A 1174/4885ALDH1A1 4409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback